liberty peptides bpc 157 BPC-157 – Labs USA BPC-157 VIAL - High Purity

This integrated tri-agonist approach produces synergistic metabolic effects that cannot be achieved with other research peptides: Source: Jastreboff et al., New England Journal of Medicine, 2023 Source: Killion et al., Nature Metabolism, 2022 Source: U.S

Several advantages of peptides, including in vivo stability, proper diffusion into tumor tissue, and low production costs, make them preferable relative to antibiotics, radiotherapy, and chemotherapy in cancer treatment

These additions do not change the reconstitution process for lyophilized vials

No FDA status Not FDA-approved Compound AOD-9604 Mechanism Modified GH fragment